Navigation Links
Drugs With Marijuana Compounds Don't Boost Adverse Events
Date:6/28/2008

But Canadian study finds increase in non-serious side effects

FRIDAY June 27 (HealthDay News) -- Drugs that contain compounds called cannabinoids from the marijuana plant don't increase the risk of serious side effects but are associated with an increase in some non-serious side effects, Canadian scientists report.

The researchers at McGill University in Montreal and the University of British Columbia (UBC) examined adverse events reported in 31 clinical studies of cannabinoid medications conducted between 1966 and 2007.

The adverse events were grouped as serious or non-serious. Serious adverse events included those that led to hospitalization, disability or death. Non-serious adverse events included dizziness and drowsiness.

"Overall, we found an 86 percent increase in the rate of non-serious adverse events among the patients treated with cannabinoids compared to the patients in the control groups," Dr. Mark Ware, a neurosciences researcher at the Research Institute of the McGill University Health Centre, said in a prepared statement.

Most of the non-serious side effects were mild to moderate in severity.

The study was published in the June 16 issue of the Canadian Medical Association Journal.

Cannabinoids have been shown to help treat chronic pain from diseases such as cancer, multiple sclerosis, arthritis and fibromyalgia. The drugs also stimulate appetite and relieve nausea, according to background information in the study.

Doctors must balance the benefits of these drugs against possible side effects, the researchers said.

"We have summarized the adverse events from these studies to help educate physicians and patients about the possible risks of medical cannabinoids. We cannot extend these results to smoked cannabis or recreational use. That will require further research," Dr. Jean-Paul Collet, senior researcher at the Child & Family Research Institute and director of the Centre for Applied Health Research and Evaluation at British Columbia Children's Hospital, said in a prepared statement.

More information

The National Pain Foundation has more about cannabinoids.



-- Robert Preidt



SOURCE: McGill University, news release, June 16, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. ADHD Gene Doesnt Predict Response to Drugs
2. Failure to Take Seizure Drugs Boosts Death Risk
3. Computers as safe as medical experts in prescribing blood thinning drugs
4. Drink and drugs fuel Scottish suicide and homicide rates
5. New Class of Drugs May Fight Alzheimers
6. Targeted Anticancer Drugs - In Vitro Assessment and Non-Invasive Imaging of Patient and Tumor Status Will Determine Clinical and Commercial Success
7. FDA Starts Safety Review of Autoimmune Disorder Drugs
8. Synthetic molecules hold promise for new family of anti-cancer drugs
9. Isis Partners Present Clinical Data on Antisense Drugs at the American Society of Clinical Oncology
10. Anemia Drugs May Speed Tumor Growth in Some Cancer Patients
11. China Nepstar Chain Drugstore Filed Its Annual Report on Form 20-F
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the technology: , ... to enable prevention of a major side effect of chemotherapy in children. Cisplatin ... patients. For cisplatin, hearing loss is FDA listed on-label as a dose limiting ...
(Date:10/12/2017)... ... , ... HMP , a leader in healthcare events and education, today announced ... Award for ‘Best B-to-B Healthcare Website.’ Winners were announced during the Eddie & Ozzie ... competition recognizes editorial and design excellence across a range of sectors. This year’s program ...
(Date:10/12/2017)... ... October 12, 2017 , ... On Saturday, October 21, the ... – Miles by Moonlight to raise money for the American Heart Association Heart Walk. ... , Teams will work together to keep their treadmills moving for 5 hours. Treadmills ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... Sept. 22, 2017 AVACEN Medical (AVACEN) announced ... now successfully helping those with the widespread pain associated ... diagnosed Amanda in Essex, England ... my hair, experiencing no sleep at all, tremendous pain, ... I cannot recommend [the AVACEN 100] enough, how this ...
(Date:9/19/2017)... LOUISVILLE, Ky. , Sept. 19, 2017   ZirMed ... and predictive analytics, today announced that it has been ranked ... the Black Book™ Rankings 2017 User Survey. ZirMed ... software solution for large hospitals and medical centers over 200 ... in Black Book,s healthcare technology user survey history. ...
(Date:9/18/2017)... 2017 EpiVax, Inc. ("EpiVax") a ... immune engineering, today announced a new NIH-funded ... ... and presents a challenge for traditional flu ... be effective. Using state-of-the-art bioinformatics and molecular modeling methods, ...
Breaking Medicine Technology: